Market Cap

Moderna, Inc. Market Capitalization:

$68.42 Billion

USD as of Jan. 1, 2023

business Moderna, Inc. Company Profile

Moderna, Inc. Main Stock Listing

show_chart NASDAQ: MRNA

Market Capitalization History of Moderna, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Moderna, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $68.42 B 4.85%
Jan. 1, 2022 $65.25 B -2.21%
Jan. 1, 2021 $66.73 B 744.27%
Jan. 1, 2020 $7.90 B 23.55%
Jan. 1, 2019 $6.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.

business Moderna, Inc. Company Profile

Moderna, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Moderna, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MRNA

Stock: BMV: MRNA

Stock: Bovespa: M1RN34

Stock: FSX: 0QF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.